Regulations.gov document
Biosimilarity and Interchangeability: Additional Draft Q&As on Biosimilar Development and…
Other · FDA-2011-D-0611 · posted Sep 15, 2023
Key facts
| Document ID | FDA-2011-D-0611-0091 |
|---|---|
| Title | Biosimilarity and Interchangeability: Additional Draft Q&As on Biosimilar Development and the BPCI Act; Guidance for Industry; Draft Guidance |
| Document type | Other |
| Subtype | Guidance |
| Agency | FDA |
| Docket | FDA-2011-D-0611 |
| Posted | Sep 15, 2023 |
| Comment period opens | Sep 15, 2023 |
At a glance
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: